ParcelBio logo

ParcelBio

Elevated mRNA for transformative medicines.
San Francisco , US
Gene Therapy
Synthetic Biology
Biotech
Therapeutics
Drug discovery
ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.
  • Projects
  • Team
  • Jobs
  • News
No projects yet.

This company hasn't published any projects. Be the first to launch one!

Create Your First Project
Founded2023
Team Size6
LocationUS
Websiteparcelbio.com/
🏳️
Is this your company?

Claim this listing to manage your profile, add updates, and connect with your audience.

Claim This Listing